Neurocrine Bioscience buy StockNews.com
Start price
21.06.24
/
50%
€125.00
Target price
21.06.25
-
Performance (%)
-16.84%
Price
04.10.24
€103.95
Summary
This prediction is currently active. The prediction for Neurocrine Bioscience disappoints with a performance of -16.84%. This prediction currently runs until 21.06.25. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Neurocrine Bioscience | 0.873% | 0.873% |
iShares Core DAX® | -1.114% | 3.430% |
iShares Nasdaq 100 | 1.816% | 6.911% |
iShares Nikkei 225® | 2.113% | 5.501% |
iShares S&P 500 | 2.038% | 5.327% |
Comments by StockNews_com for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by StockNews_com for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€139.75
04.08.24
04.08.24
-
04.08.25
04.08.25
-25.62%
04.10.24
04.10.24
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€135.45
27.07.24
27.07.24
-
27.07.25
27.07.25
-23.26%
04.10.24
04.10.24
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€134.65
20.07.24
20.07.24
-
20.07.25
20.07.25
-22.80%
04.10.24
04.10.24
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€126.90
20.01.24
20.01.24
-
20.01.25
20.01.25
-18.09%
04.10.24
04.10.24
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€107.85
23.09.23
23.09.23
-
23.09.24
23.09.24
-3.38%
24.09.24
24.09.24